02.06.14
AngioDynamics Inc.'s "operational excellence" plan apparently entails job creation as well as layoffs.
The Albany, N.Y.-based provider of minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, has appointed Soto as chief commercial officer, a newly created position overseeing the company's global sales and marketing initiatives. Soto's hire occurs amid an "operational excellence" program designed to save the firm $15 million to $18 million over the next three years. The program calls for the elimination of 80-100 positions at its New York facility.
Soto joined AngioDynamics in September 2012 as senior vice president of the company's Global Peripheral Vascular Franchise. In addition to his new responsibilities, he also will serve as interim leader of the Peripheral Vascular Franchise until his replacement is found. Additionally, Stephen McGill, senior vice president and general manager, International, is leaving the company.
"John Soto has had a tremendous impact on AngioDynamics, driving renewed strength in our Peripheral Vascular Franchise by integrating the AngioVac cannula and circuit into our portfolio, stabilizing the fluid management business and driving growth in the laser segment," said Joseph DeVivo, President/CEO. "While our International business has been a good growth driver for the business, it currently accounts for less than 20 percent of the company's global sales. By leveraging John's expansive background in sales and marketing, I believe we can accelerate our international performance."
Before joining AngioDynamics, Soto was senior vice president of Smith & Nephew plc's Global Hip franchise. Prior to that, he served as AngioDynamics' senior vice president of Global Sales after the company's acquired RITA Medical Systems in 2007, where he had been executive vice president of Global Sales and vice president of International Operations. Soto gained leadership experience at Computer Motion, Tyco Healthcare and U.S. Surgical. He graduated from the British Royal Navy with a degree in electronic engineering and also has a degree in medical marketing from the University of California at Los Angeles.
"John's experience spans from sales and marketing to international markets and regulatory environments, presenting us with a well-rounded leader to hone our global commercial organization," DeVivo continued. "I would also like to thank Stephen McGill for his service. During his tenure Stephen established our international presence, including building a strong team and overseeing the transition to a direct presence in several markets, positioning us well to take these next steps."
Additionally, AngioDynamics is combining its Latin American and Canadian sales teams with their U.S. counterparts.
AngioDynamics product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products.
The Albany, N.Y.-based provider of minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, has appointed Soto as chief commercial officer, a newly created position overseeing the company's global sales and marketing initiatives. Soto's hire occurs amid an "operational excellence" program designed to save the firm $15 million to $18 million over the next three years. The program calls for the elimination of 80-100 positions at its New York facility.
operational excellence” program designed to save $15 million to $18 million during the next three years. - See more at: http://www.mpo-mag.com/contents/view_breaking-news/2013-12-11/angiodynamics-strives-for-operational-excellence-cuts-jobs/#sthash.OgdEzKPv.dpuf
Soto joined AngioDynamics in September 2012 as senior vice president of the company's Global Peripheral Vascular Franchise. In addition to his new responsibilities, he also will serve as interim leader of the Peripheral Vascular Franchise until his replacement is found. Additionally, Stephen McGill, senior vice president and general manager, International, is leaving the company.
"John Soto has had a tremendous impact on AngioDynamics, driving renewed strength in our Peripheral Vascular Franchise by integrating the AngioVac cannula and circuit into our portfolio, stabilizing the fluid management business and driving growth in the laser segment," said Joseph DeVivo, President/CEO. "While our International business has been a good growth driver for the business, it currently accounts for less than 20 percent of the company's global sales. By leveraging John's expansive background in sales and marketing, I believe we can accelerate our international performance."
Before joining AngioDynamics, Soto was senior vice president of Smith & Nephew plc's Global Hip franchise. Prior to that, he served as AngioDynamics' senior vice president of Global Sales after the company's acquired RITA Medical Systems in 2007, where he had been executive vice president of Global Sales and vice president of International Operations. Soto gained leadership experience at Computer Motion, Tyco Healthcare and U.S. Surgical. He graduated from the British Royal Navy with a degree in electronic engineering and also has a degree in medical marketing from the University of California at Los Angeles.
"John's experience spans from sales and marketing to international markets and regulatory environments, presenting us with a well-rounded leader to hone our global commercial organization," DeVivo continued. "I would also like to thank Stephen McGill for his service. During his tenure Stephen established our international presence, including building a strong team and overseeing the transition to a direct presence in several markets, positioning us well to take these next steps."
Additionally, AngioDynamics is combining its Latin American and Canadian sales teams with their U.S. counterparts.
AngioDynamics product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products.